Has Lia Gore received payments from drug or device companies?

Yes. Drug and device makers reported $68,133 in general payments to Lia Gore across 28 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Lia Gore did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Lia Gore come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Lia Gore

Pediatric Hematology-Oncology · Aurora, CONPI 1649355389

Payments from drug & device makers

What this record shows

The money is spread across several categories — speaking fees (35.4%), consulting fees and travel and lodging — rather than concentrated in one kind of arrangement. Amgen accounts for 65.2% of it on its own, with 4 other manufacturers making up the rest. Among pediatric hematology-oncology clinicians in CO with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$68,133in general payments, 2019–2025

Across 28 payments — averaging $2433.30 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Amgen$44K
F. Hoffmann-la Roche AG$19K
Pfizer$4K
Jazz Pharmaceuticals Inc.$439
Novartis$125

$5,402,540in research payments, 2019–2025

Across 90 payments — averaging $60,028 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

Servier Pharmaceuticals LLC$3.3M
Servier Bioinnovation$1.7M
Amgen$172K
Takeda Pharmaceuticals U.S.A., Inc.$116K
Agios Pharmaceuticals, Inc.$52K
E.r. Squibb & Sons, L.L.C.$32K
plus $3K from 2 others

What the payments were for

Consulting fees$23,26234%
Speaking & faculty fees$24,10035%
Travel & lodging$19,61029%
Food & beverage$1,1602%

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Amgen	18	$44,440
F. Hoffmann-la Roche AG	4	$19,429
Pfizer	1	$3,700
Jazz Pharmaceuticals Inc.	4	$439
Novartis	1	$125

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$68,133 in reported general payments places this provider in the 95th percentile of 60 pediatric hematology-oncology providers in Colorado.

See all pediatric hematology-oncology providers in Colorado →

Other pediatric hematology-oncology in Aurora

Michael WangAurora$225K
Marilyn Manco JohnsonAurora$67K
Michael VernerisAurora$60K
Christopher McKinneyAurora$32K
Daniel AmbrusoAurora$30K
Taizo NakanoAurora$24K
Hesham EissaAurora$23K
Rachelle NussAurora$23K
Terry FryAurora$20K
Christopher NgAurora$16K

See the full list for Colorado →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →